Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03682120
What this trial is testing

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 372
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Testing effectiveness (Phase 2)Study completedNCT00316628
What this trial is testing

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Who this might be right for
Influenza
Novartis 50
Large-scale testing (Phase 3)Study completedNCT01161264
What this trial is testing

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects

Who this might be right for
Seasonal Influenza
Novartis Vaccines 126
Testing effectiveness (Phase 2)Study completedNCT00956449
What this trial is testing

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects

Who this might be right for
InfluenzaSeasonal Influenza
Novartis 126
Testing effectiveness (Phase 2)Study completedNCT00115531
What this trial is testing

Eldery High Dose TIV 2005

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 414
Not applicableStudy completedNCT02559505
What this trial is testing

Influenza Immunity in Children

Who this might be right for
Influenza
University of Rochester 134
Large-scale testing (Phase 3)Study completedNCT00848029
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Who this might be right for
Pre-pandemic Influenza Vaccine
Novartis Vaccines 240
Testing effectiveness (Phase 2)Study completedNCT00349141
What this trial is testing

Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 270
Post-approval studies (Phase 4)Study completedNCT05512494
What this trial is testing

Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 1,260
Testing effectiveness (Phase 2)Study completedNCT01258595
What this trial is testing

High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 300
Testing effectiveness (Phase 2)Study completedNCT00985673
What this trial is testing

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 611
Post-approval studies (Phase 4)Study completedNCT05499351
What this trial is testing

Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine

Who this might be right for
COVID-19
Sinovac Biotech Co., Ltd 3,000
Early research (Phase 1)Study completedNCT03898986
What this trial is testing

The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets

Who this might be right for
Influenza
Stanford University 18
Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 812
Testing effectiveness (Phase 2)Study completedNCT00992212
What this trial is testing

Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

Who this might be right for
Pandemic Influenza Disease
Novartis Vaccines 418
Large-scale testing (Phase 3)Study completedNCT01249183
What this trial is testing

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi Pasteur, a Sanofi Company 954
Post-approval studies (Phase 4)Study completedNCT02124161
What this trial is testing

Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.

Who this might be right for
PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE
Pfizer 882
Large-scale testing (Phase 3)Study completedNCT01773928
What this trial is testing

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 1,928
Post-approval studies (Phase 4)Study completedNCT00735475
What this trial is testing

Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Who this might be right for
Influenza
Seqirus 1,268
Next Page